Joshua H. Bilenker Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joshua H. Bilenker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joshua H. Bilenker. Joshua H. Bilenker is Director in T2 Biosystems, Inc. ($TTOO) and President & CEO in Loxo Oncology, Inc. ($LOXO) and Director in ViewRay, Inc. ($VRAY) and Director in Gossamer Bio, Inc. ($GOSS) and Director in Sana Biotechnology, Inc. ($SANA).
Latest Insider Trading Transactions of Joshua H. Bilenker
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GOSS, LOXO, SANA, TTOO, VRAY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | SANA | Sana Biotechnology ... | Bilenker Joshua H. | Director | Option Exercise | A | 25.00 | 7,000 | 175,000 | 7,000 | |
| Jun 18 2020 | GOSS | Gossamer Bio, Inc. | Bilenker Joshua H. | Director | Option Exercise | A | 12.10 | 23,500 | 284,350 | 23,500 | |
| Jun 11 2019 | GOSS | Gossamer Bio, Inc. | Bilenker Joshua H. | Director | Option Exercise | A | 19.54 | 23,500 | 459,190 | 23,500 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | D | 139.77 | 128,000 | 17,890,560 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | D | 84.88 | 300,000 | 25,464,000 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | D | 43.56 | 100,000 | 4,356,000 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | D | 26.27 | 209,000 | 5,490,430 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | D | 31.69 | 142,000 | 4,499,980 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | D | 13.67 | 318,514 | 4,354,086 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | D | 3.65 | 64,471 | 235,190 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | D | 1.18 | 27,459 | 32,511 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | D | 235.00 | 30,000 | 7,050,000 | 0 | 30 K to 0 (-100.00 %) |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | D | 235.00 | 162,707 | 38,236,145 | 0 | 162.7 K to 0 (-100.00 %) |
| Jan 02 2019 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | A | 139.77 | 128,000 | 17,890,560 | 128,000 | |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 13.67 | 10,000 | 136,700 | 318,514 | |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 13.67 | 10,000 | 136,700 | 328,514 | |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 140.61 | 100 | 14,061 | 164,407 | 164.5 K to 164.4 K (-0.06 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 140.15 | 1,200 | 168,180 | 164,507 | 165.7 K to 164.5 K (-0.72 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 139.05 | 1,100 | 152,955 | 165,707 | 166.8 K to 165.7 K (-0.66 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 137.63 | 2,407 | 331,275 | 166,807 | 169.2 K to 166.8 K (-1.42 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 136.79 | 3,393 | 464,128 | 169,214 | 172.6 K to 169.2 K (-1.97 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 135.76 | 1,153 | 156,531 | 172,607 | 173.8 K to 172.6 K (-0.66 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 134.63 | 647 | 87,106 | 173,760 | 174.4 K to 173.8 K (-0.37 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 13.67 | 10,000 | 136,700 | 174,407 | 164.4 K to 174.4 K (+6.08 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 137.39 | 100 | 13,739 | 164,407 | 164.5 K to 164.4 K (-0.06 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 136.48 | 400 | 54,592 | 164,507 | 164.9 K to 164.5 K (-0.24 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 135.04 | 2,377 | 320,990 | 164,907 | 167.3 K to 164.9 K (-1.42 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 134.31 | 2,049 | 275,201 | 167,284 | 169.3 K to 167.3 K (-1.21 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 133.00 | 2,104 | 279,832 | 169,333 | 171.4 K to 169.3 K (-1.23 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 132.09 | 2,001 | 264,312 | 171,437 | 173.4 K to 171.4 K (-1.15 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 130.58 | 969 | 126,532 | 173,438 | 174.4 K to 173.4 K (-0.56 %) |
| Dec 12 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 13.67 | 10,000 | 136,700 | 174,407 | 164.4 K to 174.4 K (+6.08 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 13.67 | 10,000 | 136,700 | 338,514 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 13.67 | 1,486 | 20,314 | 348,514 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 3.68 | 8,514 | 31,366 | 64,471 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 29,000 | 34,336 | 27,459 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 151.56 | 200 | 30,312 | 164,407 | 164.6 K to 164.4 K (-0.12 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 149.25 | 400 | 59,700 | 164,607 | 165 K to 164.6 K (-0.24 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 148.06 | 250 | 37,015 | 165,007 | 165.3 K to 165 K (-0.15 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 147.09 | 600 | 88,254 | 165,257 | 165.9 K to 165.3 K (-0.36 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 144.61 | 700 | 101,227 | 165,857 | 166.6 K to 165.9 K (-0.42 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 143.35 | 859 | 123,138 | 166,557 | 167.4 K to 166.6 K (-0.51 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 142.45 | 634 | 90,313 | 167,416 | 168.1 K to 167.4 K (-0.38 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 141.48 | 690 | 97,621 | 168,050 | 168.7 K to 168.1 K (-0.41 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 140.14 | 700 | 98,098 | 168,740 | 169.4 K to 168.7 K (-0.41 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 138.94 | 2,638 | 366,524 | 169,440 | 172.1 K to 169.4 K (-1.53 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 137.92 | 2,329 | 321,216 | 172,078 | 174.4 K to 172.1 K (-1.34 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 13.67 | 10,000 | 136,700 | 174,407 | 164.4 K to 174.4 K (+6.08 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 156.20 | 664 | 103,717 | 164,407 | 165.1 K to 164.4 K (-0.40 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 155.08 | 2,210 | 342,727 | 165,071 | 167.3 K to 165.1 K (-1.32 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 154.07 | 676 | 104,151 | 167,281 | 168 K to 167.3 K (-0.40 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 152.75 | 1,995 | 304,736 | 167,957 | 170 K to 168 K (-1.17 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 152.04 | 3,655 | 555,706 | 169,952 | 173.6 K to 170 K (-2.11 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 150.99 | 800 | 120,792 | 173,607 | 174.4 K to 173.6 K (-0.46 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 13.67 | 1,486 | 20,314 | 174,407 | 172.9 K to 174.4 K (+0.86 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 3.65 | 8,514 | 31,059 | 172,921 | 164.4 K to 172.9 K (+5.18 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 29,000 | 34,336 | 164,407 | 135.4 K to 164.4 K (+21.42 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 3.65 | 10,000 | 36,480 | 72,985 | |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 3.65 | 10,000 | 36,480 | 82,985 | |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 165.57 | 200 | 33,114 | 135,407 | 135.6 K to 135.4 K (-0.15 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 164.59 | 1,395 | 229,606 | 135,607 | 137 K to 135.6 K (-1.02 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 163.64 | 2,000 | 327,286 | 137,002 | 139 K to 137 K (-1.44 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 162.60 | 3,152 | 512,528 | 139,002 | 142.2 K to 139 K (-2.22 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 161.41 | 1,553 | 250,669 | 142,154 | 143.7 K to 142.2 K (-1.08 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 160.61 | 1,700 | 273,043 | 143,707 | 145.4 K to 143.7 K (-1.17 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 3.65 | 10,000 | 36,480 | 145,407 | 135.4 K to 145.4 K (+7.39 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 169.68 | 195 | 33,087 | 135,407 | 135.6 K to 135.4 K (-0.14 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 169.00 | 3,705 | 626,156 | 135,602 | 139.3 K to 135.6 K (-2.66 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 168.29 | 1,297 | 218,272 | 139,307 | 140.6 K to 139.3 K (-0.92 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 167.09 | 673 | 112,452 | 140,604 | 141.3 K to 140.6 K (-0.48 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 165.95 | 1,225 | 203,286 | 141,277 | 142.5 K to 141.3 K (-0.86 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 165.01 | 2,905 | 479,342 | 142,502 | 145.4 K to 142.5 K (-2.00 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 3.65 | 10,000 | 36,480 | 145,407 | 135.4 K to 145.4 K (+7.39 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 3.65 | 10,000 | 36,480 | 72,985 | |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 3.65 | 10,000 | 36,480 | 82,985 | |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 165.57 | 200 | 33,114 | 135,407 | 135.6 K to 135.4 K (-0.15 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 164.59 | 1,395 | 229,606 | 135,607 | 137 K to 135.6 K (-1.02 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 163.64 | 2,000 | 327,286 | 137,002 | 139 K to 137 K (-1.44 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 162.60 | 3,152 | 512,528 | 139,002 | 142.2 K to 139 K (-2.22 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 161.41 | 1,553 | 250,669 | 142,154 | 143.7 K to 142.2 K (-1.08 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 160.61 | 1,700 | 273,043 | 143,707 | 145.4 K to 143.7 K (-1.17 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 3.65 | 10,000 | 36,480 | 145,407 | 135.4 K to 145.4 K (+7.39 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 169.68 | 195 | 33,087 | 135,407 | 135.6 K to 135.4 K (-0.14 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 169.00 | 3,705 | 626,156 | 135,602 | 139.3 K to 135.6 K (-2.66 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 168.29 | 1,297 | 218,272 | 139,307 | 140.6 K to 139.3 K (-0.92 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 167.09 | 673 | 112,452 | 140,604 | 141.3 K to 140.6 K (-0.48 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 165.95 | 1,225 | 203,286 | 141,277 | 142.5 K to 141.3 K (-0.86 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 165.01 | 2,905 | 479,342 | 142,502 | 145.4 K to 142.5 K (-2.00 %) |
| Oct 05 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 3.65 | 10,000 | 36,480 | 145,407 | 135.4 K to 145.4 K (+7.39 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 3.65 | 2,527 | 9,218 | 92,985 | |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,473 | 8,848 | 56,459 | |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 10,000 | 11,840 | 63,932 | |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 167.32 | 962 | 160,959 | 135,407 | 136.4 K to 135.4 K (-0.71 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 166.52 | 3,402 | 566,511 | 136,369 | 139.8 K to 136.4 K (-2.43 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 165.43 | 5,636 | 932,335 | 139,771 | 145.4 K to 139.8 K (-3.88 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 3.65 | 2,527 | 9,218 | 145,407 | 142.9 K to 145.4 K (+1.77 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,473 | 8,848 | 142,880 | 135.4 K to 142.9 K (+5.52 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 171.08 | 400 | 68,430 | 135,407 | 135.8 K to 135.4 K (-0.29 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 169.89 | 200 | 33,977 | 135,807 | 136 K to 135.8 K (-0.15 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 168.51 | 800 | 134,810 | 136,007 | 136.8 K to 136 K (-0.58 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 167.38 | 1,800 | 301,287 | 136,807 | 138.6 K to 136.8 K (-1.30 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 166.49 | 2,400 | 399,570 | 138,607 | 141 K to 138.6 K (-1.70 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 165.18 | 3,700 | 611,174 | 141,007 | 144.7 K to 141 K (-2.56 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 164.16 | 700 | 114,912 | 144,707 | 145.4 K to 144.7 K (-0.48 %) |
| Sep 14 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 10,000 | 11,840 | 145,407 | 135.4 K to 145.4 K (+7.39 %) |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 10,000 | 11,840 | 73,932 | |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 10,000 | 11,840 | 83,932 | |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 160.75 | 1,300 | 208,976 | 135,407 | 136.7 K to 135.4 K (-0.95 %) |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 159.93 | 7,100 | 1,135,511 | 136,707 | 143.8 K to 136.7 K (-4.94 %) |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 159.13 | 1,600 | 254,602 | 143,807 | 145.4 K to 143.8 K (-1.10 %) |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 10,000 | 11,840 | 145,407 | 135.4 K to 145.4 K (+7.39 %) |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 160.49 | 800 | 128,389 | 135,407 | 136.2 K to 135.4 K (-0.59 %) |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 159.63 | 3,367 | 537,463 | 136,207 | 139.6 K to 136.2 K (-2.41 %) |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 158.51 | 4,233 | 670,972 | 139,574 | 143.8 K to 139.6 K (-2.94 %) |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 157.67 | 1,600 | 252,268 | 143,807 | 145.4 K to 143.8 K (-1.10 %) |
| Aug 15 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 10,000 | 11,840 | 145,407 | 135.4 K to 145.4 K (+7.39 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 93,932 | |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 101,432 | |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 182.84 | 800 | 146,271 | 135,407 | 136.2 K to 135.4 K (-0.59 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 181.21 | 1,300 | 235,570 | 136,207 | 137.5 K to 136.2 K (-0.95 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 180.08 | 1,000 | 180,081 | 137,507 | 138.5 K to 137.5 K (-0.72 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 179.08 | 2,200 | 393,978 | 138,507 | 140.7 K to 138.5 K (-1.56 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 178.19 | 2,200 | 392,023 | 140,707 | 142.9 K to 140.7 K (-1.54 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 142,907 | 135.4 K to 142.9 K (+5.54 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 191.63 | 300 | 57,490 | 135,407 | 135.7 K to 135.4 K (-0.22 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 189.43 | 300 | 56,829 | 135,707 | 136 K to 135.7 K (-0.22 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 188.29 | 802 | 151,004 | 136,007 | 136.8 K to 136 K (-0.59 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 187.39 | 3,698 | 692,957 | 136,809 | 140.5 K to 136.8 K (-2.63 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 186.39 | 1,500 | 279,577 | 140,507 | 142 K to 140.5 K (-1.06 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 184.87 | 900 | 166,383 | 142,007 | 142.9 K to 142 K (-0.63 %) |
| Jul 11 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 142,907 | 135.4 K to 142.9 K (+5.54 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 108,932 | |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 28,000 | 33,152 | 116,432 | |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 7,500 | 8,880 | 144,432 | |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 179.77 | 9,664 | 1,737,326 | 8,000 | 17.7 K to 8 K (-54.71 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 178.94 | 11,336 | 2,028,506 | 17,664 | 29 K to 17.7 K (-39.09 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 180.90 | 430 | 77,785 | 155,707 | 156.1 K to 155.7 K (-0.28 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 179.37 | 4,370 | 783,846 | 156,137 | 160.5 K to 156.1 K (-2.72 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 178.81 | 2,700 | 482,774 | 160,507 | 163.2 K to 160.5 K (-1.65 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 163,207 | 155.7 K to 163.2 K (+4.82 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 28,000 | 33,152 | 155,707 | 127.7 K to 155.7 K (+21.93 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 180.34 | 103 | 18,575 | 29,000 | 29.1 K to 29 K (-0.35 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 179.83 | 3,902 | 701,710 | 29,103 | 33 K to 29.1 K (-11.82 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 178.30 | 8,763 | 1,562,417 | 33,005 | 41.8 K to 33 K (-20.98 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 177.44 | 8,232 | 1,460,652 | 41,768 | 50 K to 41.8 K (-16.46 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 178.12 | 1,737 | 309,390 | 127,707 | 129.4 K to 127.7 K (-1.34 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 177.06 | 3,427 | 606,770 | 129,444 | 132.9 K to 129.4 K (-2.58 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 176.20 | 2,336 | 411,607 | 132,871 | 135.2 K to 132.9 K (-1.73 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 7,500 | 8,880 | 135,207 | 127.7 K to 135.2 K (+5.87 %) |
| Jun 21 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Gift | G | 0.00 | 5,000 | 0 | 127,707 | 132.7 K to 127.7 K (-3.77 %) |